Report Of Exempt Distribution.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10541 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Report Of Exempt Distribution.

posted on Apr 16, 2024 03:39PM

Promissory Note out of Alberta

Dated: April 11, 2024.

Amt: $543,120.00 CAN

With 700K Warrants, Expire, April 11, 2029 @ $1.03.

Koo

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply